Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun;3(2):96-102.
doi: 10.1007/BF00239745.

Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects

Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects

N Manca et al. Eur J Epidemiol. 1987 Jun.

Abstract

Sera from 51 HTLV-III (human immunodeficiency virus, HIV)-antibody positive subjects consisting of 21 asymptomatic individuals and 15 ARC and 15 AIDS patients were analyzed for their serological profiles toward the viral antigens. One of the asymptomatic subjects only showed a p24 reactivity in the immunoblot, but antibodies to the env antigens were clearly identified by immunoprecipitation of viral antigens (RIP) followed by SDS-polyacrylamide gel electrophoresis. RIP patterns of different subjects and even different bleeds from the same subjects showed a varying reactivity to the gag antigens whereas the reactivity towards the env antigens appeared to be generally stable. RIP analysis of sequential sera of virus-infected individuals indicated a pattern consistent with an initial steady rise of antibody reactivities to the gag antigens relative to the reactivities to the envelope antigens. These reactivities reached a plateau and then slowly declined. While all sera tested had antibodies to the envelope antigens gp160, gp120 and gp41, 86% of the asymptomatic subjects, 67% of the ARC patients and only 33% of the AIDS patients had antibodies to the gag proteins p24 and pr53gag.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1986 Apr;58(1):9-16 - PubMed
    1. Lancet. 1984 Jun 30;1(8392):1438-40 - PubMed
    1. Science. 1984 May 4;224(4648):500-3 - PubMed
    1. N Engl J Med. 1986 Jan 9;314(2):131-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed

Publication types

LinkOut - more resources